Search results

11 results for Tofacitinib

Sorted by Relevance . Sort by Date

  1. Tofacitinib for moderately to severely active ulcerative colitis (TA547)

    Evidence-based recommendations on tofacitinib (Xeljanz) for previously treated moderately to severely active ulcerative colitis in adults

  2. Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs (TA543)

    Evidence-based recommendations on tofacitinib (Xeljanz) for treating active psoriatic arthritis after inadequate response to DMARDs in adults

  3. Spondyloarthritis

    Everything NICE has said on diagnosing and managing spondyloarthritis in people aged 16 and over in an interactive flowchart

  4. Rheumatoid arthritis

    Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart

  5. Ulcerative colitis

    Everything NICE has said on managing ulcerative colitis in adults, children and young people in an interactive flowchart

  6. Block scoping reports

    This information helps ministers to decide whether or not a technology should be formally referred to NICE for appraisal and whether it should be referred as an MTA or an STA.

  7. Ulcerative colitis: management (NG130)

    This guideline covers the management of ulcerative colitis in children, young people and adults. It aims to help professionals to provide consistent high-quality care and it highlights the importance of advice and support for people with ulcerative colitis.